Abstract
In an Editorial (Jan 29, p 353),1 you express concern about the effects of the Health and Social Care Bill on the UK's National Health Service (NHS). In claiming that the introduction of financial considerations in clinical decision making (through so-called clinically led commissioning) might signal the end of the NHS, you take sides in the long-running debate about the costs and benefits of competition in health care.2,3 Although such debates about the pros and cons of market mechanisms mostly revolve around abstract arguments, our empirical study of the effects of market reforms introduced in the Netherlands in 2005 suggests a mixed picture.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
More From: The Lancet
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
